Analysis of veno-venous extracorporeal membrane oxygenation treatment strategies and literature review for the first case of human infection with H10N3 avian influenza complicated by severe acute respiratory distress syndrome in Guangxi.

Objective
To explore the application value and feasibility of veno-venous extracorporeal membrane oxygenation (VV-ECMO) in the treatment of patients infected with H10N3 avian influenza complicated with severe acute respiratory distress syndrome (ARDS).
Method
A retrospective analysis was performed on the process and effect of VV-ECMO adjuvant treatment in the first case of human infection with H10N3 avian influenza complicated with ARDS in Guangxi.
Result
The main clinical manifestations of the patient were fever, cough and shortness of breath. The patient was confirmed to be infected with H10N3 avian influenza by the Chinese Center for Disease Control and Prevention (China CDC) through deep sequencing of influenza virus in respiratory samples. After receiving VVECMO supportive treatment, the pulmonary lesions were absorbed, and the patient ultimately recovered.
Conclusion
The application of VV-ECMO in patients infection with H10N3 avian influenza complicated with ARDS has shown remarkable therapeutic effects. It can efficiently provide oxygenation and remove carbon dioxide, winning precious time for disease control and pulmonary function recovery, and significantly improving patient survival rates.